MTEMQ (Molecular Templates) Total Liabilities: $19.59 Mil (As of Jun. 2024)


MTEMQ Molecular Templates Inc MTEMQ
12 GF Score
Price $0.00
View Full Analysis

What is Molecular Templates Total Liabilities?

Molecular Templates MTEMQ 12 Total Liabilities is $19.59 Mil as of Jun. 2024. GuruFocus rates MTEMQ with a GF Score™ of 12/100.

Molecular Templates's Total Liabilities for the quarter that ended in Jun. 2024 was $19.59 Mil.

Molecular Templates's quarterly Total Liabilities declined from Dec. 2023 ($31.17 Mil) to Mar. 2024 ($21.25 Mil) and declined from Mar. 2024 ($21.25 Mil) to Jun. 2024 ($19.59 Mil).

Molecular Templates's annual Total Liabilities declined from Dec. 2021 ($126.70 Mil) to Dec. 2022 ($112.68 Mil) and declined from Dec. 2022 ($112.68 Mil) to Dec. 2023 ($31.17 Mil).


Molecular Templates Total Liabilities Historical Data

* Premium members only.

The historical data trend for Molecular Templates's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Molecular Templates Total Liabilities Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 71.17 80.54 126.70 112.68 31.17

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 44.19 37.26 31.17 21.25 19.59
MTEMQ
12GF Score
Molecular Templates Inc MTEMQ
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Molecular Templates Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Molecular Templates's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=17.321+(9.742+4.108
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=31.17

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=35.383-4.212
=31.17

Molecular Templates's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=26.697-7.111
=19.59

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $19.59 Mil mean?
Molecular Templates (MTEMQ) has a Total Liabilities of $19.59 Mil as of Jun. 2024. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Molecular Templates and its competitors.
Is Molecular Templates' Total Liabilities too high?
Molecular Templates' current Total Liabilities is $19.59 Mil. Overall, Molecular Templates has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Molecular Templates' Total Liabilities compare to GRTSQ and ARTHQ?
Molecular Templates' Total Liabilities of $19.59 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Molecular Templates and its competitors. Molecular Templates's current Total Liabilities is $19.59 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Molecular Templates stock overvalued right now?
Molecular Templates (MTEMQ) has a current Total Liabilities of $19.59 Mil. The current Total Liabilities is $19.59 Mil. Molecular Templates' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Molecular Templates (MTEMQ), the current Total Liabilities is $19.59 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Molecular Templates Business Description

Address 9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer. Its pipeline products are MT-6402, MT-8421 and MT-0169.
12GF Score

Get the complete analysis for MTEMQ

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price